TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006
TCL Archive Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors. June 17, 2005